Plasma Fractionation Market Analysis and Growth Forecast by 2030

MarkNtel Advisors, a leading market research and consulting firm, has announced the release of its latest study titled Plasma Fractionation Market Research Report: Forecast (2025–2030). This report provides a detailed assessment of the Plasma Fractionation, covering its evolving dynamics, emerging trends, key growth drivers, major challenges, and competitive landscape.

Designed to guide investors, stakeholders, and business leaders, the research aims to deliver valuable insights for strategic planning, risk assessment, and investment decision-making in the years ahead.

Market Timeline Overview

• Historical Years: 2020–23
• Base Year: 2024
• Forecast Years: 2025–30

This helps businesses identify emerging opportunities, assess market risks, and develop data-driven strategies for long-term success.

Download a FREE PDF Sample of the Report: - https://www.marknteladvisors.com/query/request-sample/plasma-fractionation-market.html  (Discover the market potential, platform-specific insights, and key industry trends.)

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Plasma Fractionation Market Outlook

The Global Plasma Fractionation Market size was valued at around USD 31.18 billion in 2024 and is projected to reach USD 42.39 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.51% during the forecast period, i.e., 2025-30. The demand for plasma-derived therapy has been increasing worldwide, owing to the prevalence of rare disorders in the global population. In 2023, according to the Rare Disease Day Organization, around 300 million people worldwide are living with a rare disorder.

Plasma Fractionation Market Drivers:

Escalating Geriatric Population Driving the Demand for Plasma-derived Therapies – Globally, the surging geriatric population has resulted in a substantial boost in the incidences of diseases like immunodeficiency, neurological disorders, etc., which require plasma-derived therapies for treatment. The increment in the geriatric population has been attributed to the increasing life expectancy of the elderly population in various countries like China, Japan, etc., as a result of their improved healthcare infrastructure. Consequently, as the number of geriatric patients has been increasing, there has been an enhanced demand for plasma-derived therapeutic products, presenting a strong market situation for plasma fractionation manufacturers, particularly immunoglobulins and coagulation factors during historical years.

View Full Report (All Data, In One Place): - https://www.marknteladvisors.com/research-library/plasma-fractionation-market.html  (Explore in-depth analyses, technological trends, and investment patterns.)

Plasma Fractionation Market Trends:

Expansion of Plasma Fractionation Plants Gaining Traction – The growing positive outcomes of plasma-derived drugs for chronic, autoimmune, and other diseases have raised the demand for plasma fractionation products in the market. The booming demand for plasma fractionation products has prompted global players in the Plasma Fractionation Market, such as Takeda Pharmaceuticals and Grifols, to embark on a trend of establishing new plasma fractionation manufacturing facilities worldwide. For instance.

Plasma Fractionation Market Segmentation

The study categorizes the Plasma Fractionation into various segments and sub-segments, each analyzed for its size, growth potential, and contribution to the overall industry.

By Product

• Immunoglobulin- Market Size & Forecast 2020-2030, (USD Million)
  • Intravenous Immunoglobulin- Market Size & Forecast 2020-2030, (USD Million)
  • Subcutaneous Immunoglobulin- Market Size & Forecast 2020-2030, (USD Million)
  • Other Disease Specific Immunoglobulins (Hepatitis B Immunoglobulin, Tetanus Immunoglobulin, etc.) - Market Size & Forecast 2020-2030, (USD Million)
• Coagulation Factors- Market Size & Forecast 2020-2030, (USD Million)
  • Factor VIII- Market Size & Forecast 2020-2030, (USD Million)
  • Factor IX- Market Size & Forecast 2020-2030, (USD Million)
  • Von Willebrand Factor (vWF) - Market Size & Forecast 2020-2030, (USD Million)
  • Prothrombin Complex Concentrates- Market Size & Forecast 2020-2030, (USD Million)
  • Fibrinogen Concentrates- Market Size & Forecast 2020-2030, (USD Million)
  • Factor XIII- Market Size & Forecast 2020-2030, (USD Million)
  • Others (Factor VIIa, Factor XI, etc.)- Market Size & Forecast 2020-2030, (USD Million)
• Albumin- Market Size & Forecast 2020-2030, (USD Million)
• Protease Inhibitor- Market Size & Forecast 2020-2030, (USD Million)
• Others (Plasminogen, Antithrombin III, etc.) - Market Size & Forecast 2020-2030, (USD Million)

By Application

• Neurology- Market Size & Forecast 2020-2030, (USD Million)
• Immunology- Market Size & Forecast 2020-2030, (USD Million)
• Hematology- Market Size & Forecast 2020-2030, (USD Million)
• Critical Care- Market Size & Forecast 2020-2030, (USD Million)
• Pulmonology- Market Size & Forecast 2020-2030, (USD Million)
• Rheumatology- Market Size & Forecast 2020-2030, (USD Million)
• Others (Oncology, Pediatrics, etc.) - Market Size & Forecast 2020-2030, (USD Million)

By End User

• Hospitals - Market Size & Forecast 2020-2030, (USD Million)
• Specialty Clinics- Market Size & Forecast 2020-2030, (USD Million)
• Research Facilities - Market Size & Forecast 2020-2030, (USD Million)

Geographical Analysis

The report presents detailed insights into the market’s geographical expansion, highlighting key trends and opportunities across the following geographies:

By Region

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific.

Talk to Our Industry Analyst:  - https://www.marknteladvisors.com/query/talk-to-our-consultant/plasma-fractionation-market.html  Get personalized insights into company strategies and regional market dynamics.)

Leading Companies in Plasma Fractionation Market Worldwide: Players, Analysis & Future Outlook

• Biotest A.G.
• Octapharma A.G.
• Adma Biologics
• Aegros
• CSL Limited
• Grifols S.A.
• Kedrion Biopharma Inc.
• Bio Products Laboratory Ltd                                  
• Takeda Pharmaceuticals
• Emergent Bio solutions
• Intas Pharmaceutical
• Plasma Gen Biosciences
• S K Plasma
• Australian Red Cross Lifeblood
•  

Key Highlights of the Report

• Comprehensive Market Overview: In-depth analysis of market size, share, and forecasts from 2025 to 2030.
• Growth Drivers & Challenges: Clear insights into factors feeling or restraining market expansion.
• Investment & Regulatory Insights: Evaluation of key policies, funding trends, and collaborations influencing industry performance.
• Competitive Landscape: Detailed profiles of leading companies, including product portfolios, business strategies, financials, and recent developments such as mergers & acquisitions.

Analytical Tools: Application of SWOT Analysis, PESTEL Analysis, and Porter’s Five Forces Model to assess competition and external influences

Browse through our flexible pricing plans and choose the package that best fits your business needs whether you require a single-user license, corporate access, or customized insights. Once you select the plan that suits your requirements, you can purchase and instantly access the full report online – https://www.marknteladvisors.com/pricing/plasma-fractionation-market.html   

Frequently Asked Questions (FAQ)

1. What is the projected growth rate of the Plasma Fractionation?
   2. What are the major factors driving this market’s growth?
   3. Which regions are expected to lead the Plasma Fractionation?
   4. Who are the prominent players in the Plasma Fractionation?
   5. How is the competition structured in this market?
   6. How can I access the full report?

About Us

MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.

Contact Us:
MarkNtel Advisors
Sector 63, Noida, Uttar Pradesh-201301, India
Contact No: +91 87199 99009
Email: sales@marknteladvisors.com
Website: https://www.marknteladvisors.com